BioFabric, the Brazilian-based bio-printing and biotechnology company, has raised $25 million in funding, the company said Tuesday.
BioFabric’s new investor will be Softbank.
Softbank, which was founded in 2000 by SoftBank Group, owns the popular Japanese mobile phone maker Softbank NISCO, and has been looking for investors for some time.
BioFABric, which is based in São Paulo, Brazil, has a global presence.
It provides high-end manufacturing to biotechnology companies for their biopharmaceutical products, such as biodegradable biofuels and vaccines, and for medical implants.
Bio Fabric said the funding will help it expand its global manufacturing operations.
The company is now focusing on expanding its product range, which includes fabrics, garments and biofabric materials.
The BioFabrics new investor, SoftBank, has been known for its aggressive financing practices.
SoftBank owns a majority stake in BioFabries parent company BioFABRIC.
SoftCo, which SoftBank acquired for $1.2 billion in 2014, is the largest shareholder of SoftBank.
The two companies have also formed an investment partnership to build a research center in the United States.